LUTS - BPH
2008
Daily Use of PDE5-Inhibitors: The Road to Happiness?
Gratzke C
Based on:
Endothelial Rehabilitation: The Impact of Chronic PDE5 Inhibitors on Erectile Function and Protein Alterations in Cavernous Tissue of Diabetic Rats
De Young LX, Domes T, Lim KB et al
Prostate Cancer Following BPH Treatments: What the Patient Should Know
Gilling PJ
Based on:
Nerve-Sparing Radical Retropubic Prostatectomy in Patients Previously Submitted to Holmium Laser Enucleation of the Prostate for Bladder Outlet Obstruction Due to Benign Prostatic Enlargement
Suardi N, Scattoni V, BrigantiA, et al
Phosphodiesterase Type 5 Inhibitors Improve Male Lower Urinary Tract Symptoms
Giuliano F
Rebuttal from Author re: François Giuliano. Phosphodiesterase Type 5 Inhibitors Improve Male Lower Urinary Tract Symptoms. Eur Urol 2008;53:1121–3
Stief CG
The above two editorials are based on the following article:
A Randomised, Placebo-Controlled Study to Assess the Efficacy of Twice-Daily Vardenafil in the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
Stief CG, Porst H, Neuser D et al
Red Wine, Sex, and a Genius
Bartoletti R, Mondaini N, Cai T
2007
Medical Management of BPH: The Debate Continues
Debruyne FMJ
Drug treatment for LUTS and BPH: New is not always better
Roehrborn CG
Lasers for the Treatment of Bladder Outlet Obstruction: Are They Challenging Conventional Treatment Modalities?
de la Rosette J, Alivizatos G
Laser Vaporization of the Prostate: Are We there Yet?
Gilling PJ
Based on:
The diode laser: a novel side-firing approach for laser vaporisation of the human
prostate - immediate efficacy and 1-year follow-up
Seitz, Sroka, Gratzke et al.






